Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine.
about
Sex-associated differences in the antibody-dependent cellular cytotoxicity antibody response to measles vaccines.Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trialSex-specific differences in mortality after high-titre measles immunization in rural Senegal.Measles control in developing and developed countries: the case for a two-dose policy.Evidence that measles virus hemagglutinin initiates modulation of leukocyte function-associated antigen 1 expressionImmunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years.Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up.Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial.Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial.Negative Correlation between Circulating CD4+FOXP3+CD127- Regulatory T Cells and Subsequent Antibody Responses to Infant Measles Vaccine but Not Diphtheria-Tetanus-Pertussis Vaccine Implies a Regulatory Role.Sex-Differential Non-Vaccine-Specific Immunological Effects of Diphtheria-Tetanus-Pertussis and Measles Vaccination.
P2860
Q33998162-1C10A80D-B5DA-426A-A7C6-C14281AF3E01Q34152512-20635875-F694-445F-86C7-1074987FE0ABQ34325187-F51DFF68-7684-46A9-8D30-69602A1E1411Q34730474-468A5D0D-2A4C-4BA1-8F09-9D0EB05F2869Q35841633-1FB8B113-D029-4F43-BA3C-72ECF914DD44Q36106722-38053D92-79E4-48FD-9A6B-8D086F09D13FQ36504062-F9ACF512-F932-4C7B-AB3A-284E4601793FQ36818026-134CBA8B-848D-4BB2-A57E-E5E2953027B8Q36871954-E9BE0B58-791F-4C2E-822A-B23E606AA442Q38635328-C9299B14-7400-413F-A594-2E520EDECCB8Q39307915-33793EF9-660A-41AA-9A1F-25CC31634C2F
P2860
Antibody persistence in Gambian children after high-dose Edmonston-Zagreb measles vaccine.
description
1990 nî lūn-bûn
@nan
1990 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Antibody persistence in Gambia ...... onston-Zagreb measles vaccine.
@ast
Antibody persistence in Gambia ...... onston-Zagreb measles vaccine.
@en
Antibody persistence in Gambia ...... onston-Zagreb measles vaccine.
@nl
type
label
Antibody persistence in Gambia ...... onston-Zagreb measles vaccine.
@ast
Antibody persistence in Gambia ...... onston-Zagreb measles vaccine.
@en
Antibody persistence in Gambia ...... onston-Zagreb measles vaccine.
@nl
prefLabel
Antibody persistence in Gambia ...... onston-Zagreb measles vaccine.
@ast
Antibody persistence in Gambia ...... onston-Zagreb measles vaccine.
@en
Antibody persistence in Gambia ...... onston-Zagreb measles vaccine.
@nl
P2093
P921
P1433
P1476
Antibody persistence in Gambia ...... onston-Zagreb measles vaccine.
@en
P2093
H C Whittle
H Campbell
J R Armstrong
P304
P356
10.1016/0140-6736(90)92501-8
P407
P577
1990-10-01T00:00:00Z